共 50 条
Combination treatment with platycodin D and osthole inhibits cell proliferation and invasion in mammary carcinoma cell lines
被引:45
作者:
Ye, Yiyi
[1
]
Han, Xianghui
[1
]
Guo, Baofeng
[1
]
Sun, Zhenping
[2
]
Liu, Sheng
[1
,2
]
机构:
[1] Longhua Hosp, Pharmacol Lab Tradit Chinese Med, Shanghai 200032, Peoples R China
[2] Longhua Hosp, Dept Breast Surg, Shanghai 200032, Peoples R China
基金:
中国国家自然科学基金;
关键词:
Platycodin D;
Osthole;
Combination treatment;
Murine;
4T1;
cells;
Human MDA-MB-231 cells;
Anti-invasion;
TGF-BETA;
MESENCHYMAL TRANSITION;
BONE METASTASIS;
CANCER-CELLS;
KAPPA-B;
TUMOR;
EXPRESSION;
SPECIFICITY;
APOPTOSIS;
PATHWAY;
D O I:
10.1016/j.etap.2013.03.012
中图分类号:
X [环境科学、安全科学];
学科分类号:
08 ;
0830 ;
摘要:
In this study, two invasive mammary carcinoma cells (MDA-MB-231 and 4T1) were utilized to evaluate the inhibitory activities of platycodin D, osthole, and the two in combination. The anti-proliferative effect was tested using the MTT and BrdU assay, and the combination of 15 mu M osthole and 75 mu M platycodin D was used for subsequent analyses. The anti-invasive effect was evaluated by the transwell assay. The results showed that the combination treatment reduced both cell proliferation and invasion. Western blot and real-time PCR revealed that the platycodin D-osthole combination significantly decreased T beta RII, Smad2, Smad3 and Smad4 gene or protein expressions, as well as effectively blocked TGF-beta-induced phosphorylation of Smad2 and Smad3. Thus, this study demonstrates that the anti-cancer effects of the platycodin D-osthole combination in breast cancer cells involve proliferation inhibition and invasion blockade, both of which maybe mediated by perturbations in the TGF-beta/Smads pathway. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:115 / 124
页数:10
相关论文
共 50 条